Mercado del microbioma humano: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPBT00002233
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 188
Buy Now

Se espera que el mercado del microbioma humano alcance los 2.921,68 millones de dólares en 2028, frente a los 718,95 millones de dólares de 2021; se estima que crecerá a una tasa compuesta anual del 22,2 % durante 2021-2028.

La microbiota humana está formada por billones de células microbianas simbióticas que cada persona alberga, principalmente bacterias en el intestino. Los microbios, incluidas bacterias, hongos y virus, son agentes causantes de enfermedades que se acumulan con el tiempo y el hábitat en el intestino transforma sus actividades genéticas y procesos metabólicos, lo que resulta en una respuesta inmune anormal contra las sustancias y tejidos que normalmente se presentan en el intestino. el cuerpo humano. Se han lanzado varios proyectos de microbiomas en todo el mundo con el objetivo de comprender las funciones que desempeñan estos simbiontes y su impacto en la salud del huésped humano. El crecimiento del mercado del microbioma humano se atribuye a factores como la creciente incidencia de enfermedades del estilo de vida, el creciente enfoque en las terapias del microbioma humano y los crecientes avances tecnológicos en metagenómica y secuenciación de próxima generación. Sin embargo, las estrictas directrices gubernamentales y la falta de conocimiento sobre un examen detallado obstaculizan el crecimiento del mercado.  

regiones lucrativas para el mercado del microbioma humano


Mercado Ideas

Creciente incidencia de enfermedades relacionadas con el estilo de vida

En las últimas décadas, los investigadores han aclarado la relación entre el microbioma humano y las enfermedades relacionadas con el estilo de vida, como el cáncer, la diabetes y la obesidad. y depresión. Los cambios en los estilos de vida y las normas sociales influyen en el microbioma en cada etapa de la vida. La alteración del microbioma humano puede ayudar a eliminar estas enfermedades relacionadas con el estilo de vida. Según la Organización Mundial de la Salud, el 13% de la población mundial (adultos) era obesa en 2016. Según "La nueva era del tratamiento para la obesidad y los trastornos metabólicos: evidencia y expectativas para el trasplante de microbioma intestinal", 13% de la población mundial (adultos) era obesa en 2016. Publicado en 2016, los microbios que residen en el tracto gastrointestinal humano actúan como un órgano endocrino cuya composición y funcionalidad contribuyen al desarrollo de la obesidad. Por lo tanto, el trasplante de microbioma fecal/intestino (GMT), que implica la transferencia de heces de un donante sano al paciente, es un tratamiento potencial para la obesidad.

La diabetes es una de las emergencias sanitarias mundiales del siglo XXI. Según la Federación Internacional de Diabetes (FID), el número de personas que padecían diabetes en América del Norte era de ~46 millones en 2017, y se espera que aumente a 62 millones en 2045, es decir, con una prevalencia de la enfermedad de ~35% durante el período de pronóstico. Los niveles reducidos de Firmicutes Clostridia indican el microbioma de los pacientes con diabetes con bacterias productoras de butirato y una mayor proporción de Bacteroidetes: Firmicutes. Por tanto, la diabetes se puede prevenir y tratar alterando el microbioma mediante la administración de prebióticos, probióticos y trasplantes fecales. Por lo tanto, la creciente incidencia de enfermedades crónicas relacionadas con el estilo de vida está impulsando el crecimiento del mercado del microbioma humano.

Información basada en el producto

Basado en el producto, el ser humano El mercado de microbiomas se segmenta en alimentos, alimentos médicos, probióticos, prebióticos, medicamentos, dispositivos de diagnóstico y suplementos. Se proyecta que el segmento de probióticos tendrá la mayor participación de mercado en 2021, y se anticipa que el segmento de prebióticos registre la CAGR más alta del mercado durante el período de pronóstico.

Humanos Mercado de microbiomas, por producto: 2021 y 2028

Cobertura del informe

Información basada en enfermedades

El mercado del microbioma humano, por enfermedad, se segmenta en diabetes, cáncer , trastornos autoinmunes, obesidad, trastornos mentales y otras enfermedades. El mercado del microbioma humano está surgiendo debido a la creciente incidencia de enfermedades relacionadas con el estilo de vida, como el cáncer y la diabetes. Se espera que el segmento de obesidad tenga la mayor participación del mercado en 2021, mientras que se estima que el segmento de diabetes registre la CAGR más alta durante el período de pronóstico.

Aplicación- Insights basados

El mercado del microbioma humano, por aplicación, se segmenta en diagnóstico y terapéutica. Se proyecta que el segmento terapéutico tendrá una mayor participación de mercado en 2021 y, además, se estima que registrará una CAGR más alta durante el período de pronóstico.

Perspectivas estratégicas

Los lanzamientos y aprobaciones de productos son estrategias comúnmente adoptadas por las empresas para expandir su presencia global y sus carteras de productos. Las empresas del mercado del microbioma humano se centran en la estrategia de colaboración para ampliar su clientela, lo que, a su vez, les permite mantener su marca en todo el mundo.

Microbioma humano Mercado: por Producto

  • Probióticos
  • Alimentos
  • Prebióticos
  • Alimentos medicinales
  • Dispositivos de diagnóstico
  • Medicamentos
  • Suplementos

Mercado del microbioma humano: por enfermedad

  • Obesidad
  • Diabetes
  • Trastornos autoinmunes
  • Cáncer
  • Trastornos mentales< /li>
  • Otros

 Mercado del microbioma humano: por aplicación   

  • Terapéutica
  • Diagnóstico

Mercado del microbioma humano: por Geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • < li>Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
    • Resto de Europa
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de Asia Pacífico
  • Medio Oriente y África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
    • Resto de Oriente Medio y África
  • Sur y Centroamérica (SCAM)
    • Brasil
    • Argentina
    • Resto de Sudamérica y Centroamérica
< h3>Perfiles de la empresa
  • Rebiotix Inc.
  • Yakult Honsha Co., Ltd.
  • Synthetic Biologics Inc.
  • DuPont
  • MaaT Pharma
  • Eligo Bioscience
  • Merck & Co. Inc
  • AOBiome LLC
  • Kaleido
  • Seres Therapeutics
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the regional analysis in terms of human microbiome market?

The Asia Pacific human microbiome market is analyzed based on the five major countries such as China, Japan, India, Australia, South Korea, and the rest of Asia Pacific. The Asia Pacific region is expected to be the fastest-growing region among all other regions. The rise in the collaborations among the Asian countries and Western countries for the research activities and the extensive genomic research in China are to likely drive the human microbiome market in the forecast period. In May 2018, The Conference on Human Microbiome and Chronic Disease, hosted by the Institute of Microbiology, Chinese Academy of Sciences and Chinese Society of Biotechnology was held in China National Convention Center at Beijing. The aim was to promote research human microbiome and related technology. Thus, there is a huge potential for human microbiome market in the region during the forecast period owing to the above-mentioned factors.

What are the driving factors for the human microbiome market across the globe?

The growth of the human microbiome market is attributed to the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies, and growing technological advancements in metagenomics and next-generation sequencing. However strict government guidelines and lack of knowledge about detailed examination hinders the market growth.

What is human microbiome?

The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person, mainly bacteria in the gut. The microbes including bacteria, fungi and viruses are the disease-causing microbes that accumulate over time and changing their gene activity & metabolic processes and resulting in an abnormal immune response against the substances and tissues that normally present in the human body.

The List of Companies - Human Microbiome Market

  1. Rebiotix Inc.
  2. Yakult Honsha Co., Ltd.
  3. Synthetic Biologics Inc.
  4. DuPont
  5. MaaT Pharma
  6. Eligo Bioscience
  7. Merck & Co. Inc
  8. AOBiome LLC
  9. Kaleido
  10. Seres Therapeutics

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports